Privia Health Group Stock Price, News & Analysis (NASDAQ:PRVA) $22.10 +0.16 (+0.73%) (As of 11/28/2023 ET) Add Compare Share Share Today's Range$21.57▼$22.2550-Day Range$20.42▼$23.6552-Week Range$19.68▼$30.15Volume485,460 shsAverage Volume1.13 million shsMarket Capitalization$2.61 billionP/E Ratio71.29Dividend YieldN/APrice Target$34.64 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Privia Health Group MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside56.7% Upside$34.64 Price TargetShort InterestBearish6.63% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.93Based on 2 Articles This WeekInsider TradingSelling Shares$1.32 M Sold Last QuarterProj. Earnings Growth45.45%From $0.22 to $0.32 Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.74 out of 5 starsMedical Sector165th out of 949 stocksHealth Services Industry3rd out of 12 stocks 3.5 Analyst's Opinion Consensus RatingPrivia Health Group has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 9 buy ratings, no hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $34.64, Privia Health Group has a forecasted upside of 56.7% from its current price of $22.10.Amount of Analyst CoveragePrivia Health Group has only been the subject of 1 research reports in the past 90 days. Previous Next 1.0 Short Interest Percentage of Shares Shorted6.63% of the float of Privia Health Group has been sold short.Short Interest Ratio / Days to CoverPrivia Health Group has a short interest ratio ("days to cover") of 7.2.Change versus previous monthShort interest in Privia Health Group has recently increased by 1.66%, indicating that investor sentiment is decreasing. Previous Next 0.0 Dividend Strength Dividend YieldPrivia Health Group does not currently pay a dividend.Dividend GrowthPrivia Health Group does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for PRVA. Previous Next 2.7 News and Social Media Coverage News SentimentPrivia Health Group has a news sentiment score of 0.93. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.80 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 2 news articles for Privia Health Group this week, compared to 2 articles on an average week.Search InterestOnly 1 people have searched for PRVA on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.MarketBeat Follows7 people have added Privia Health Group to their MarketBeat watchlist in the last 30 days. This is an increase of 75% compared to the previous 30 days. Previous Next 4.2 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Privia Health Group insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $1,321,248.00 in company stock.Percentage Held by Insiders44.80% of the stock of Privia Health Group is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions92.40% of the stock of Privia Health Group is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 3.1 Earnings and Valuation Earnings GrowthEarnings for Privia Health Group are expected to grow by 45.45% in the coming year, from $0.22 to $0.32 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Privia Health Group is 71.29, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 121.66.Price to Earnings Ratio vs. SectorThe P/E ratio of Privia Health Group is 71.29, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 130.93.Price to Earnings Growth RatioPrivia Health Group has a PEG Ratio of 2.86. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioPrivia Health Group has a P/B Ratio of 4.88. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Privia Health Group Stock (NASDAQ:PRVA)Privia Health Group, Inc. operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings. It offers technology and population health tools to enhance independent providers' workflows; management services organization that enable providers to focus on their patients by reducing administrative work; single-TIN medical group that facilitates payer negotiation, clinical integration and alignment of financial incentives; accountable care organization, which engage patients, reduce inappropriate utilization, and enhance coordination and patient quality metrics to drive value-based care; and network for purchasers and payers that enable providers to connect with new patient populations and create custom contracts. The company was founded in 2007 and is headquartered in Arlington, Virginia. Privia Health Group, Inc. is a subsidiary of Brighton Health Group Holdings, LLC.Read More PRVA Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart PRVA Stock News HeadlinesNovember 24, 2023 | morningstar.comPrivia Health Group IncNovember 19, 2023 | americanbankingnews.comPrivia Health Group (NASDAQ:PRVA) Given New $38.00 Price Target at JPMorgan Chase & Co.November 29, 2023 | Autonomix (Ad)[Investor Alert] Potential Breakthrough Medical Tech Investment OpportunityAutonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.comNovember 6, 2023 | finance.yahoo.comPrivia Health Group, Inc. (NASDAQ:PRVA) Q3 2023 Earnings Call TranscriptNovember 5, 2023 | seekingalpha.comPrivia Health Group, Inc. 2023 Q3 - Results - Earnings Call PresentationNovember 4, 2023 | finance.yahoo.comPrivia Health Group, Inc.'s (NASDAQ:PRVA) P/S Still Appears To Be ReasonableNovember 4, 2023 | finance.yahoo.comQ3 2023 Privia Health Group Inc Earnings CallNovember 3, 2023 | finance.yahoo.comPrivia Health (PRVA) Q3 Earnings Miss EstimatesNovember 29, 2023 | Autonomix (Ad)[Investor Alert] Potential Breakthrough Medical Tech Investment OpportunityAutonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.comNovember 3, 2023 | finance.yahoo.comCompared to Estimates, Privia Health (PRVA) Q3 Earnings: A Look at Key MetricsNovember 3, 2023 | finance.yahoo.comOMCL vs. PRVA: Which Stock Should Value Investors Buy Now?November 3, 2023 | finance.yahoo.comPrivia Health Reports Third Quarter 2023 Financial Results; Announces New Market Entry in South CarolinaNovember 3, 2023 | finance.yahoo.comPrivia Health Group Inc (PRVA) Reports 21.7% Increase in Q3 RevenueOctober 12, 2023 | finance.yahoo.comIs Now The Time To Look At Buying Privia Health Group, Inc. (NASDAQ:PRVA)?October 11, 2023 | finance.yahoo.comPrivia Health to Report Third Quarter 2023 Results on Friday, November 3September 14, 2023 | finance.yahoo.comBe Wary Of Privia Health Group (NASDAQ:PRVA) And Its Returns On CapitalSeptember 6, 2023 | finance.yahoo.comPrivia Health to Participate in the Morgan Stanley Healthcare ConferenceAugust 25, 2023 | finance.yahoo.comPrivia Health Reports Results in CMS’ Medicare Shared Savings Program for the 2022 Performance YearAugust 25, 2023 | finance.yahoo.comPrivia Health Reports Results in CMS’ Medicare Shared Savings Program for the 2022 Performance YearAugust 19, 2023 | markets.businessinsider.com4 Analysts Have This to Say About Privia Health GrAugust 17, 2023 | finance.yahoo.comGEHC or PRVA: Which Is the Better Value Stock Right Now?August 16, 2023 | msn.comPrivia Health: Unit Economics Stretching Higher At Qualified Growth Rates (Rating Upgrade)August 16, 2023 | msn.comTD Cowen Maintains Privia Health Group (PRVA) Outperform RecommendationAugust 4, 2023 | finance.yahoo.comIs Privia Health Group, Inc.'s (NASDAQ:PRVA) Stock Price Struggling As A Result Of Its Mixed Financials?August 3, 2023 | finance.yahoo.comPrivia Health (PRVA) Q2 Earnings and Revenues Surpass EstimatesAugust 3, 2023 | finance.yahoo.comPrivia Health Reports Second Quarter 2023 Financial ResultsAugust 1, 2023 | finance.yahoo.comPrivia Health to Enter Washington StateSee More Headlines Receive PRVA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Privia Health Group and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/03/2023Today11/28/2023Fiscal Year End12/31/2023Next Earnings (Estimated)2/27/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Health services Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:PRVA CUSIPN/A CIK1759655 Webwww.priviahealth.com Phone571-366-8850FaxN/AEmployees964Year FoundedN/APrice Target and Rating Average Stock Price Target$34.64 High Stock Price Target$41.00 Low Stock Price Target$26.00 Potential Upside/Downside+56.7%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage9 Analysts Profitability EPS (Most Recent Fiscal Year)$0.31 Trailing P/E Ratio71.29 Forward P/E Ratio100.45 P/E Growth2.86Net Income$-8,590,000.00 Net Margins2.40% Pretax Margin1.78% Return on Equity6.80% Return on Assets4.23% Debt Debt-to-Equity RatioN/A Current Ratio1.77 Quick Ratio1.77 Sales & Book Value Annual Sales$1.36 billion Price / Sales1.92 Cash FlowN/A Price / Cash FlowN/A Book Value$4.53 per share Price / Book4.88Miscellaneous Outstanding Shares118,060,000Free Float65,171,000Market Cap$2.61 billion OptionableNot Optionable Beta0.87 A Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for December 2023. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesMr. Parth Mehrotra (Age 44)CEO & Director Comp: $1.37MMr. David Mountcastle CPA (Age 53)MBA, Executive VP, CFO & Principal Accounting Officer Comp: $882.07kMr. Thomas Bartrum (Age 56)Executive VP & General Counsel Comp: $608.79kMr. Chris VoigtExecutive VP & Chief Technology OfficerMr. Robert P. BorchertSenior Vice President of Investor Relations & Corporate CommunicationsMs. Dana Fields CPASenior VP of Internal Audit & Chief Compliance OfficerMs. Jenny HardingSenior Vice President of People OperationsMr. Jay StevensSenior VP & Chief Growth OfficerDr. S. Mark Cone FACOG (Age 60)M.D., President of Privia Medical Group - Gulf Coast Texas Mr. Eric J. BeyerExecutive Vice President of Medical GroupsMore ExecutivesKey CompetitorsLifeStance Health GroupNASDAQ:LFSTU.S. Physical TherapyNYSE:USPHInnovAgeNASDAQ:INNVAmphastar PharmaceuticalsNASDAQ:AMPHiRhythm TechnologiesNASDAQ:IRTCView All CompetitorsInsiders & InstitutionsPublic Sector Pension Investment BoardSold 40,094 shares on 11/22/2023Ownership: 0.107%Polar Capital Holdings PlcSold 7,933 shares on 11/22/2023Ownership: 0.018%Walleye Capital LLCBought 60,612 shares on 11/21/2023Ownership: 0.051%Comerica BankBought 53,398 shares on 11/21/2023Ownership: 0.045%The Manufacturers Life Insurance Company Bought 798 shares on 11/15/2023Ownership: 0.072%View All Insider TransactionsView All Institutional Transactions PRVA Stock Analysis - Frequently Asked Questions Should I buy or sell Privia Health Group stock right now? 9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Privia Health Group in the last year. There are currently 9 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" PRVA shares. View PRVA analyst ratings or view top-rated stocks. What is Privia Health Group's stock price target for 2024? 9 equities research analysts have issued 1-year price objectives for Privia Health Group's stock. Their PRVA share price targets range from $26.00 to $41.00. On average, they predict the company's stock price to reach $34.64 in the next year. This suggests a possible upside of 56.7% from the stock's current price. View analysts price targets for PRVA or view top-rated stocks among Wall Street analysts. How have PRVA shares performed in 2023? Privia Health Group's stock was trading at $22.71 at the start of the year. Since then, PRVA stock has decreased by 2.7% and is now trading at $22.10. View the best growth stocks for 2023 here. When is Privia Health Group's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, February 27th 2024. View our PRVA earnings forecast. How were Privia Health Group's earnings last quarter? Privia Health Group, Inc. (NASDAQ:PRVA) released its quarterly earnings results on Friday, November, 3rd. The company reported $0.05 EPS for the quarter, hitting the consensus estimate of $0.05. The business earned $417.30 million during the quarter, compared to the consensus estimate of $410.51 million. Privia Health Group had a trailing twelve-month return on equity of 6.80% and a net margin of 2.40%. The firm's revenue for the quarter was up 21.7% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.01 earnings per share. What ETFs hold Privia Health Group's stock? ETFs with the largest weight of Privia Health Group (NASDAQ:PRVA) stock in their portfolio include Global X Telemedicine & Digital Health ETF (EDOC), Invesco S&P SmallCap Health Care ETF (PSCH), SPDR S&P Health Care Services ETF (XHS), BNY Mellon Innovators ETF (BKIV), ROBO Global Healthcare Technology and Innovation ETF (HTEC), Fidelity Disruptive Medicine ETF (FMED), First Trust Nasdaq Lux Digital Health Solutions ETF (EKG) and Franklin Genomic Advancements ETF (HELX). When did Privia Health Group IPO? (PRVA) raised $351 million in an initial public offering (IPO) on Thursday, April 29th 2021. The company issued 19,500,000 shares at $17.00-$19.00 per share. Goldman Sachs, J.P. Morgan, Credit Suisse, Piper Sandler and William Blair served as the underwriters for the IPO and Canaccord Genuity, Truist Securities, R. Seelaus & Co. and Siebert Williams Shank were co-managers. Who are Privia Health Group's major shareholders? Privia Health Group's stock is owned by a number of retail and institutional investors. Top institutional shareholders include FMR LLC (12.09%), Bank of New York Mellon Corp (3.44%), Riverbridge Partners LLC (3.40%), Principal Financial Group Inc. (2.99%), Invesco Ltd. (1.46%) and Avidity Partners Management LP (1.31%). Insiders that own company stock include Advisors LLC Mbd, David Mountcastle, Jeffrey B Butler, Jeffrey Daniel Bernstein, Matthew Shawn Morris, Pamplona Capital Partners Iii,, Parth Mehrotra, Thomas Bartrum and William M Sullivan. View institutional ownership trends. How do I buy shares of Privia Health Group? Shares of PRVA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. This page (NASDAQ:PRVA) was last updated on 11/29/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Privia Health Group, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.